Abstract
Background and Aims: Poor medication adherence undermines treatment outcomes. With polypharmacy getting increasingly common, adherence becomes a growing concern. We sought to conduct a survey regarding polypharmacy, adherence and health-related quality of life (HRQoL) in community-dwelling old patients with various co-morbidities, all at high cardiovascular disease (CVD) risk, who were receiving polypharmacy. We also investigated the relation of polypharmacy-adherence-HRQoL and their associations with patient characteristics.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
